Research / CALY / Fundamental state Inspectable configuration
State dimensions Filing 0000837465-26-000010 General Corporate
Debt relative to revenue 25th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
68.73% · OPTIONAL · VALID
Capex intensity 0th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
1.54% · OPTIONAL · VALID
Operating cash generation 70th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
16.21% · OPTIONAL · VALID
Revenue growth 0th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
-51.40% · CORE · VALID
Inventory pressure 25th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
30.35% · OPTIONAL · VALID
Gross margin 12th Own-history percentile · N=17
Evidence method Level · gp.fundamentals.gross_margin
42.11% · CORE · VALID
Operating margin 35th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
6.22% · CORE · VALID
R&D intensity 100th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
3.18% · OPTIONAL · VALID
SBC intensity 65th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
1.16% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 38 states Self-history eligible
Sep 30, 2021 9/9 normalized Level 3 Dec 31, 2021 8/8 normalized Level 3 Mar 31, 2022 8/8 normalized Level 3 Jun 30, 2022 8/8 normalized Level 3 Sep 30, 2022 8/8 normalized Level 3 Dec 31, 2022 8/8 normalized Level 3 Mar 31, 2023 8/8 normalized Level 3 Jun 30, 2023 8/8 normalized Level 3 Sep 30, 2023 8/8 normalized Level 3 Dec 31, 2023 8/8 normalized Level 3 Mar 31, 2024 8/8 normalized Level 3 Jun 30, 2024 8/8 normalized Level 3 Sep 30, 2024 8/8 normalized Level 3 Dec 31, 2024 8/8 normalized Level 3 Mar 31, 2025 8/8 normalized Level 3 Jun 30, 2025 8/8 normalized Level 3 Sep 30, 2025 8/8 normalized Level 3 Dec 31, 2025 9/9 normalized Level 3 Mar 31, 2026 9/9 normalized Level 3 Jun 30, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 156.68%
Current 68.73%
Delta -87.95% Capex Intensity Decreased
Previous 7.10%
Current 1.54%
Delta -5.55% Cash Generation Decreased
Previous 24.45%
Current 16.21%
Delta -8.24% Growth Decreased
Previous -7.79%
Current -51.40%
Delta -43.62% Inventory Pressure Decreased
Previous 60.89%
Current 30.35%
Delta -30.54% Profitability Increased
Previous 3.03%
Current 6.22%
Delta 3.19% R And D Intensity Increased
Previous 2.15%
Current 3.18%
Delta 1.03% Sbc Intensity Increased
Previous 0.42%
Current 1.16%
Delta 0.74% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.